Article
Author(s):
Washington-As Congress moves toward possible approval of a new prescriptiondrug program for Medicare recipients later this summer, determination ofpayments for cancer drugs and therapeutic services may well hang in thebalance.
Money Matters: Go into 2025 strong with this year-end financial checklist
Health policy in urology: 2024 AUA Advocacy Summit recap
Money Matters: Financial considerations when getting married
How APPs can bridge the gap in urologist shortages
ChatGPT shows promise in responding to urology patient in-basket messages
Money Matters: Using donor-advised funds to avoid paying capital gains taxes